TELMI-AM Tablet
Powerful Dual Therapy for Hypertension and Cardiovascular Protection
Composition
Telmisartan 40 mg + Amlodipine 5 mg
- Pack: 10 x 10 Tablets
- Prescription medicine
- Available to order
Overview
TELMI - AM combines Telmisartan, an angiotensin II receptor blocker (ARB), with Amlodipine, a calcium channel blocker (CCB), offering complementary mechanisms to effectively manage high blood pressure. This combination helps relax blood vessels, improve blood flow, and lower cardiovascular risk.
Key Benefits
- Enhanced Blood Pressure Control: Dual-action formula reduces blood pressure more effectively than monotherapy
- Vascular Protection: Prevents blood vessel constriction and improves circulation
- Cardiovascular Risk Reduction: Lowers the risk of heart attack, stroke, and other complications in hypertensive patients
- Once-Daily Convenience: Simplifies treatment and improves patient adherence
- Well-Tolerated: Proven safety profile with minimal side effects
Indications
- Hypertension (Primary and Resistant): For patients not adequately controlled with either agent alone
- Cardiovascular Risk Reduction: In patients with comorbid conditions like diabetes, kidney disease, or high cardiovascular risk
- Stable Angina & Coronary Artery Disease: Supports long-term heart health
